Imatinib for chronic myeloid leukaemia: a NICE mess

Lancet. 2001 Dec 1;358(9296):1902-3. doi: 10.1016/s0140-6736(01)06902-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Financing, Government*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • National Health Programs / economics
  • Piperazines / economics*
  • Piperazines / therapeutic use
  • Pyrimidines / economics*
  • Pyrimidines / therapeutic use
  • United Kingdom

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate